Related Experiment Video

Updated: Jun 25, 2026

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

Peptides for tumour therapy and diagnosis: current status and future directions

Laura Zaccaro1, Annarita Del Gatto, Carlo Pedone

  • 1Department of Biological Sciences, University of Naples Federico II, via Mezzocannone 16, 80134, Napoli, Italy.

Current Medicinal Chemistry
|March 12, 2009
PubMed

Insights

Radiolabeled peptides show promise as radiopharmaceuticals for cancer imaging and therapy. This review highlights recent advances in designing peptides that target specific receptors involved in tumor diseases.

Area of Science:

  • Nuclear medicine
  • Radiopharmaceutical chemistry
  • Oncology

Background:

  • Peptides are validated targeting tools with applications in various fields.
  • Radiolabeled peptides are crucial radiopharmaceuticals for cancer imaging and therapy due to their stability and binding properties.

Purpose of the Study:

  • To review recent progress in the design and synthetic modifications of small biologically active peptides.
  • To focus on the development of peptides targeting cholecystokinin (CCK), somatostatin, and integrin receptors relevant to tumor diseases.

Main Methods:

  • Review of literature on peptide design and synthesis for radiopharmaceuticals.
  • Analysis of recent developments in targeting specific biological receptors (CCK, somatostatin, integrin).

Main Results:

  • Significant progress has been made in designing and modifying peptides for targeted cancer applications.
  • Optimization of peptides for targeting CCK, somatostatin, and integrin receptors involved in specific tumor pathologies is ongoing.

Conclusions:

  • Small biologically active peptides are increasingly important in cancer diagnosis and therapy.
  • Further development of targeted radiolabeled peptides holds significant potential for improving cancer care.

More Related Videos

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Peptide Identification Using Tandem Mass Spectrometry01:33

Peptide Identification Using Tandem Mass Spectrometry

Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: